Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 10.4 EX-10.4
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.17 EX-10.17
- 10.21 EX-10.21
- 10.22 EX-10.22
- 10.23 EX-10.23
- 10.24 EX-10.24
- 10.25 EX-10.25
- 10.26 EX-10.26
- 10.27 EX-10.27
- 10.28 EX-10.28
- 10.29 EX-10.29
- 10.30 EX-10.30
- 10.31 EX-10.31
- 10.32 EX-10.32
- 10.33 EX-10.33
- 10.34 EX-10.34
- 10.35 EX-10.35
- 10.37 EX-10.37
- 10.38 EX-10.38
- 10.39 EX-10.39
- 10.40 EX-10.40
- 10.41 EX-10.41
- 10.42 EX-10.42
- 23.1 EX-23.1
Quark Pharmaceuticals similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated September 24, 2010, (except Notes 1 and 15, as to which the date is November 24, 2010) in the Registration Statement (Form S-1 No. 333-169584) and the related Prospectus of Quark Pharmaceuticals, Inc. dated November 24, 2010.
November 24, 2010 | /s/ Kost Forer Gabbay & Kasierer |
Tel-Aviv, Israel | Kost Forer Gabbay & Kasierer |
A Member of Ernst & Young Global |